Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000912057-97-011300
Filing Date
1997-03-31
Accepted
1997-03-31 00:00:00
Documents
6
Period of Report
1996-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 10-K405 10-K405 243464
2 EXHIBIT 10.29 CONSULTING SERVICES AGREEMENT EX-10.29 15369
3 EXHIBIT 10.31 1997 RESEARCH AGREEMENT AMENDMENT EX-10.31 5954
4 EXHIBIT 11.1 STATEMENT REGARDING CALCULATION EX-11.1 2773
5 EXHIBIT 23.1 CONSENT OF KPMG PEAT MARWICK EX-23.1 978
6 FDS EX-27.1 2007
  Complete submission text file 0000912057-97-011300.txt   272474
Mailing Address
Business Address 420 CHIPETA WAY SUITE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

EIN.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-23272 | Film No.: 97570231
SIC: 2836 Biological Products, (No Diagnostic Substances)